tradingkey.logo
tradingkey.logo
Pesquisar

Bausch + Lomb Corp

BLCO
Adicionar à lista de desejos
16.540USD
-0.090-0.54%
Fechamento 06/30, 16:00ETCotações atrasadas em 15 min
5.86BValor de mercado
PerdaP/L TTM

Mais detalhes de Bausch + Lomb Corp Empresa

Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.

Informações de Bausch + Lomb Corp

Código da empresaBLCO
Nome da EmpresaBausch + Lomb Corp
Data de listagemMay 06, 2022
CEOSaunders (Brenton L)
Número de funcionários13500
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 06
Endereço520 Applewood Crescent
CidadeVAUGHAN
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísCanada
Código postalL4K 4B4
Telefone19082552864
Sitehttps://ir.bausch.com/
Código da empresaBLCO
Data de listagemMay 06, 2022
CEOSaunders (Brenton L)

Executivos da empresa Bausch + Lomb Corp

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Luc Bonnefoy
Mr. Luc Bonnefoy
President - Surgical
President - Surgical
87.02K
-1.16%
Dr. Yehia Hashad, M.D.
Dr. Yehia Hashad, M.D.
Executive Vice President - Research & Development, Chief Medical Officer
Executive Vice President - Research & Development, Chief Medical Officer
72.80K
-18.77%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
57.52K
+62.90%
Mr. Russel C. Robertson
Mr. Russel C. Robertson
Independent Director
Independent Director
27.66K
+57.27%
Mr. Sam A. Eldessouky
Mr. Sam A. Eldessouky
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Thomas W. Ross, Sr.
Mr. Thomas W. Ross, Sr.
Lead Independent Director
Lead Independent Director
--
--
Mrs. Nathalie Bernier
Mrs. Nathalie Bernier
Independent Director
Independent Director
--
--
Dr. Andrew Charles Von Eschenbach, M.D.
Dr. Andrew Charles Von Eschenbach, M.D.
Independent Director
Independent Director
--
--
Ms. Sarah B. Kavanagh
Ms. Sarah B. Kavanagh
Independent Director
Independent Director
--
--
Mr. John A. Paulson ,
Mr. John A. Paulson ,
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Luc Bonnefoy
Mr. Luc Bonnefoy
President - Surgical
President - Surgical
87.02K
-1.16%
Dr. Yehia Hashad, M.D.
Dr. Yehia Hashad, M.D.
Executive Vice President - Research & Development, Chief Medical Officer
Executive Vice President - Research & Development, Chief Medical Officer
72.80K
-18.77%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
57.52K
+62.90%
Mr. Russel C. Robertson
Mr. Russel C. Robertson
Independent Director
Independent Director
27.66K
+57.27%
Mr. Sam A. Eldessouky
Mr. Sam A. Eldessouky
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Thomas W. Ross, Sr.
Mr. Thomas W. Ross, Sr.
Lead Independent Director
Lead Independent Director
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Bausch + Lomb Corp?

Os cinco principais acionistas de Bausch + Lomb Corp são: Mr. Luc Bonnefoy

Quantas instituições possuem ações da Bausch + Lomb Corp (BLCO)?

Em 2026Q1, 249 instituições possuíam ações da Bausch + Lomb Corp, com valor de mercado aproximado de 40.30M, representando 11.30% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -25007155.00.

Qual é a maior fonte de receita da Bausch + Lomb Corp?

Em 2026Q1, o segmento de negócios Devices gerou a maior receita para Bausch + Lomb Corp, totalizando 1.92B e representando 37.68% da receita total.
KeyAI